Trial Profile
Bacterial microbiota analysis of stool samples collected during the Phase 1b study of andecaliximab in Ulcerative Colitis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2017
Price :
$35
*
At a glance
- Drugs Andecaliximab (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics; Therapeutic Use
- 04 Dec 2017 New trial record
- 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week